Sebia FLC Kappa, Sebia FLC Lambda

Sebia launched two serum-free light chain assays for multiple myeloma testing. The tests called sebia FLC Kappa and sebia FLC Lambda use an ELISA format and were developed to provide more consistent results by overcoming the challenges in analytical performance and coherence often seen in currently available testing methods, the firm said. The assays are CE marked, and Sebia intends to apply for 510(k) clearance for them later this year.